Stefan Oelrich

Stefan Oelrich is a member of the Board of Management of Bayer AG and President of its Pharmaceuticals Division, headquartered in Berlin, Germany. Since being appointed to these roles in 2018, Stefan Oelrich has spearheaded a transformation of Bayer’s Pharmaceuticals business, focusing on key areas of healthcare innovation to improve the lives of patients. Oelrich first joined Bayer AG in 1989, assuming leadership positions of increasing strategic importance in Latin America (Argentina, Uruguay), Europe (France, Belgium), and the United States. During Oelrich’s seven-year tenure at Sanofi, he led the organization’s Germany, Switzerland and Austria organizations, and then went on to build up Sanofi’s diabetes and cardiovascular business. Oelrich was appointed Executive Vice President Diabetes & Cardiovascular and Member of Sanofi’s Executive Committee in 2016. Oelrich has been a Member of the Supervisory Board of Charité since 2020. In June 2025, Oelrich was appointed President of the European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents the biopharmaceutical industry operating in Europe.